The immunophysiology and apoptosis of biliary epithelial cells: Primary biliary cirrhosis and primary sclerosing cholangitis

Clinical Reviews in Allergy and Immunology

Volumn 43, Issue 3, 2012, Pages 230-241

  Kawata, Kazuhito ^a,b   Kobayashi, Yoshimasa ^b   Gershwin, M Eric ^a   Bowlus, Christopher L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Autoimmunity; Biliary epithelial cells; Primary biliary cirrhosis; Primary sclerosing cholangitis

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CATHELICIDIN; CD2 ANTIGEN; CD40 ANTIGEN; CX3C CHEMOKINE; FAS LIGAND; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MITOCHONDRION ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; OXOGLUTARATE DEHYDROGENASE; PROTEIN P53; PYRUVATE DEHYDROGENASE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; URSODEOXYCHOLIC ACID;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; BILIARY EPITHELIAL CELL; CANCER RISK; CD4+ T LYMPHOCYTE; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EPITHELIUM CELL; GENETIC POLYMORPHISM; GRANULOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LEUKOCYTE; LIVER TRANSPLANTATION; MULTIPLE SCLEROSIS; PHAGOCYTE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM;

ANIMALS; APOPTOSIS; BILE DUCTS; CHOLANGITIS, SCLEROSING; EPITHELIAL CELLS; HUMANS; LIVER CIRRHOSIS, BILIARY;

EID: 84871645959     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-012-8324-0     Document Type: Article

References (114)

1. Harada K, Ohba K, Ozaki S et al (2004) Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology 40:925-932 (Pubitemid 39288126)
2. Yokoyama T, Komori A, Nakamura M et al (2006) Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int 26:467-476
3. Chen XM, O'Hara SP, Nelson JB et al (2005) Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol 175:7447-7456 (Pubitemid 41713442)
4. Savill J, Dransfield I, Gregory C, Haslett C (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2:965-975 (Pubitemid 37323217)
5. Ravichandran KS, Lorenz U (2007) Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol 7:964-974 (Pubitemid 350166061)
6. LleoA, Invernizzi P, Selmi C et al (2007)Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 29:61-68 (Pubitemid 47393611)
7. Salunga TL, Cui ZG, Shimoda S et al (2007) Oxidative stressinduced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun 29:78-86 (Pubitemid 47385107)
8. Allina J, Hu B, Sullivan DM et al (2006) T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27:232-241 (Pubitemid 46199127)
9. Torok NJ (2007) Apoptotic cell death takes its toll. Hepatology 46:1323-1325 (Pubitemid 350155511)
10. Schiller M, Bekeredjian-Ding I, Heyder P, Blank N, Ho AD, Lorenz HM (2008) Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ 15:183-191 (Pubitemid 350286186)
11. Lucas M, Stuart LM, Savill J, Lacy-Hulbert A (2003) Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J Immunol 171:2610-2615 (Pubitemid 37025573)
12. Nagata S, Hanayama R, Kawane K (2010) Autoimmunity and the clearance of dead cells. Cell 140:619-630
13. Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261-1273 (Pubitemid 41345948)
14. Gershwin ME, Mackay IR, Sturgess A, Coppel RL (1987) Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138:3525-3531 (Pubitemid 17071942)
15. Lleo A, Selmi C, Invernizzi P et al (2009) Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 49:871-879
16. Rong G, Zhong R, Lleo A et al (2011) Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis. Hepatology 54:196-203
17. Lleo A, Bowlus CL, Yang GX et al (2010) Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 52:987-998
18. Tinmouth J, Lee M,Wanless IR, Tsui FW, Inman R, Heathcote EJ (2002) Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 22:228-234 (Pubitemid 34846361)
19. Anderson KV (2000) Toll signaling pathways in the innate immune response. Curr Opin Immunol 12:13-19 (Pubitemid 30093445)
20. Kaisho T, Akira S (2002) Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 1589:1-13 (Pubitemid 34242898)
21. Harada K, Isse K, Nakanuma Y (2006) Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction. J Clin Pathol 59:184-190 (Pubitemid 43235585)
22. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335-376 (Pubitemid 37174535)
23. Wang AP, Migita K, Ito M et al (2005) Hepatic expression of tolllike receptor 4 in primary biliary cirrhosis. J Autoimmun 25:85-91 (Pubitemid 41008670)
24. Karrar A, Broome U, Sodergren T et al (2007) Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 132:1504-1514 (Pubitemid 46627575)
25. Harada K, Ohira S, Isse K et al (2003) Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest 83:1657-1667 (Pubitemid 37421106)
26. Harada K, Sato Y, Itatsu K et al (2007) Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology 46:1146-1154 (Pubitemid 350144779)
27. Chen XM, O'Hara SP, LaRusso NF (2008) The immunobiology of cholangiocytes. Immunol Cell Biol 86:497-505
28. Harada K, Isse K, Sato Y, Ozaki S, Nakanuma Y (2006) Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M. Liver Int 26:935-942 (Pubitemid 44323411)
29. Fellermann K, Stange EF (2001) Defensins -innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol 13:771-776 (Pubitemid 32656589)
30. Taylor K, Barran PE, Dorin JR (2008) Structure-Activity relationships in beta-defensin peptides. Biopolymers 90:1-7
31. Yang D, Liu ZH, Tewary P, Chen Q, de la Rosa G, Oppenheim JJ (2007) Defensin participation in innate and adaptive immunity. Curr Pharm Des 13:3131-3139 (Pubitemid 350130962)
32. D'Aldebert E, Biyeyeme Bi Mve MJ, Mergey M et al (2009) Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology 136:1435-1443
33. Morland CM, Fear J, McNab G, Joplin R, Adams DH (1997) Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc Assoc Am Physicians 109:372-382 (Pubitemid 27287735)
34. Isse K, Harada K, Zen Y et al (2005) Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology 41:506-516 (Pubitemid 40289497)
35. Shimoda S, Harada K, Niiro H et al (2010) CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis. Hepatology 51:567-575
36. Selmi C, Mackay IR, Gershwin ME (2007) The immunological milieu of the liver. Semin Liver Dis 27:129-139 (Pubitemid 46871659)
37. Yokomori H, Oda M, Ogi M et al (2005) Expression of adhesion molecules on mature cholangiocytes in canal of Hering and bile ductules in wedge biopsy samples of primary biliary cirrhosis. World J Gastroenterol 11:4382-4389 (Pubitemid 41093958)
38. Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, Luscinskas FW (2005) ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-Alpha-Activated vascular endothelium under flow. Blood 106:584-592 (Pubitemid 40981255)
39. Leon MP, Bassendine MF, Gibbs P, Thick M, Kirby JA (1997) Immunogenicity of biliary epithelium: study of the adhesive interaction with lymphocytes. Gastroenterology 112:968-977 (Pubitemid 27113824)
40. Cruickshank SM, Southgate J, Selby PJ, Trejdosiewicz LK (1998) Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro. J Hepatol 29:550-558 (Pubitemid 28484943)
41. Adams DH, Afford SC (2002) The role of cholangiocytes in the development of chronic inflammatory liver disease. Front Biosci 7:e276-e285
42. Aagaard BD, Heyworth MF, Oesterle AL, Jones AL, Way LW (1996) Intestinal immunisation with Escherichia coli protects rats against Escherichia coli induced cholangitis. Gut 39:136-140 (Pubitemid 26239121)
43. Mostov KE (1994) Transepithelial transport of immunoglobulins. Annu Rev Immunol 12:63-84 (Pubitemid 24140409)
44. Nakagawa T, Zhu H, Morishima N et al (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403:98-103 (Pubitemid 30038529)
45. Ashkenazi A (2002) Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2:420-430 (Pubitemid 37328939)
46. Takeda K, Kojima Y, Ikejima K et al (2008) Death receptor 5 mediated-Apoptosis contributes to cholestatic liver disease. Proc Natl Acad Sci U S A 105:10895-10900
47. Bai J, Odin JA (2003) Apoptosis and the liver: relation to autoimmunity and related conditions. Autoimmun Rev 2:36-42 (Pubitemid 37443870)
48. Lleo A, Selmi C, Invernizzi P, Podda M, Gershwin ME (2008) The consequences of apoptosis in autoimmunity. J Autoimmun 31:257-262
49. Ravichandran KS (2011) Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 35:445-455
50. Oikawa T, Takahashi H, Ishikawa T et al (2007) Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease. Pathol Int 57:485-492 (Pubitemid 47030132)
51. Mataki N, Kikuchi K, Kawai T et al (2007) Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases. Am J Gastroenterol 102:302-312 (Pubitemid 46160544)
52. Afford SC, Ahmed-Choudhury J, Randhawa S et al (2001) CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB J 15:2345-2354 (Pubitemid 33063163)
53. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I (1997) Immunosuppressive effects of apoptotic cells. Nature 390:350-351
54. Huynh ML, Fadok VA, Henson PM (2002) Phosphatidylserinedependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109:41-50 (Pubitemid 34052540)
55. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101:890-898 (Pubitemid 28096086)
56. Henson PM (2005) Dampening inflammation. Nat Immunol 6:1179-1181 (Pubitemid 43045625)
57. Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317-1330 (Pubitemid 24091790)
58. Casiano CA, Martin SJ, Green DR, Tan EM (1996) Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med 184:765-770 (Pubitemid 26324132)
59. Casciola-Rosen LA, Anhalt GJ, Rosen A (1995) DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 182:1625-1634
60. Huang FP, Platt N, Wykes M et al (2000) A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 191: 435-444
61. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N (2000) Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191:423-434
62. Johansson U, Walther-Jallow L, Smed-Sorensen A, Spetz AL (2007) Triggering of dendritic cell responses after exposure to activated, but not resting, apoptotic PBMCs. J Immunol 179:1711-1720
63. Rovere P, Manfredi AA, Vallinoto C et al (1998) Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein I antibodies. J Autoimmun 11:403-411 (Pubitemid 28520195)
64. Frisoni L, McPhie L, Colonna L et al (2005) Nuclear autoantigen translocation and autoantibody opsonization lead to increased dendritic cell phagocytosis and presentation of nuclear antigens: a novel pathogenic pathway for autoimmunity? J Immunol 175: 2692-2701 (Pubitemid 41113885)
65. Tzeng TC, Suen JL, Chiang BL (2006) Dendritic cells pulsed with apoptotic cells activate self-reactive T-cells of lupus mice both in vitro and in vivo. Rheumatology (Oxford) 45:1230-1237
66. Gershwin ME, Mackay IR (2008) The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47:737-745 (Pubitemid 351280742)
67. Mao TK, Davis PA, Odin JA, Coppel RL, Gershwin ME (2004) Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. Hepatology 40:1241-1248 (Pubitemid 39656995)
68. Moteki S, Leung PS, Coppel RL et al (1996) Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 24:97-103 (Pubitemid 26249419)
69. Moteki S, Leung PS, Dickson ER et al (1996) Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosisusing recombinant 2-oxoglutarate dehydrogenase complex. Hepatology 23:436-444
70. Miyakawa H, Tanaka A, Kikuchi K et al (2001) Detection of antimitochondrial autoantibodies in immunofluorescent AMAnegative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 34:243-248 (Pubitemid 32702335)
71. Oertelt S, Rieger R, Selmi C et al (2007) A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 45:659-665 (Pubitemid 46450617)
72. Muratori P, Muratori L, Ferrari R et al (2003) Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 98:431-437 (Pubitemid 36232395)
73. Liu H, Norman GL, Shums Z et al (2010) PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 35:436-442
74. Agmon-Levin N, Shapira Y, Selmi C et al (2010) A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun 34:55-58
75. Hu CJ, Zhang FC, Li YZ, Zhang X (2010) Primary biliary cirrhosis: what do autoantibodies tell us? World J Gastroenterol 16:3616-3629
76. Gershwin ME, Selmi C, Worman HJ et al (2005) Risk factors and comorbidities in primary biliary cirrhosis: a controlled interviewbased study of 1032 patients. Hepatology 42:1194-1202 (Pubitemid 43112687)
77. Selmi C, Gershwin ME, Lindor KD et al (2007) Quality of life and everyday activities in patients with primary biliary cirrhosis. Hepatology 46:1836-1843
78. Hirschfield GM, Liu X, Xu C et al (2009) Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360:2544-2555
79. Liu X, Invernizzi P, Lu Y et al (2010) Genome-wide metaanalyses identify three loci associated with primary biliary cirrhosis. Nat Genet 42:658-660
80. Hunt KA, Zhernakova A, Turner G et al (2008) Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 40:395-402 (Pubitemid 351450876)
81. International Multiple Sclerosis Genetics Consortium (IMSGC) (2010) IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun 11:397-405
82. Remmers EF, Plenge RM, Lee AT et al. (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357:977-986. (Pubitemid 47367077)
83. Amano K, Leung PS, Rieger R et al (2005) Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 174:5874-5883 (Pubitemid 40593233)
84. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ (2009) Primary biliary cirrhosis. Hepatology 50:291-308
85. Kita H, Lian ZX, Van deWater J et al (2002) Identification of HLAA2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med 195:113-123 (Pubitemid 34074501)
86. Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y (1995) HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 181:1835-1845
87. Van de Water J, Ansari A, Prindiville T et al (1995) Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 181:723-733
88. Kita H, Matsumura S, He XS et al (2002) Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 109:1231-1240 (Pubitemid 34496601)
89. Shimoda S, Van de Water J, Ansari A et al (1998) Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 102:1831-1840 (Pubitemid 28533830)
90. Yang GX, Lian ZX, Chuang YH et al (2008) Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 47:1974-1982
91. Ueno Y, Ambrosini YM, Moritoki Y, Ridgway WM, Gershwin ME (2010) Murine models of autoimmune cholangitis. Curr Opin Gastroenterol 26:274-279
92. Wakabayashi K, Lian ZX, Moritoki Y et al (2006) IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology 44:1240-1249 (Pubitemid 44748374)
93. Tsuda M, Ambrosini YM, Zhang Wet al (2011) Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis. Hepatology 54:1293-1302
94. Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A (2001) Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 108:223-232 (Pubitemid 32656246)
95. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K (1997) Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 25:1077-1084 (Pubitemid 27199930)
96. Harada K, Ozaki S, Gershwin ME, Nakanuma Y (1997) Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 26:1399-1405 (Pubitemid 27520002)
97. Sakisaka S, Koga H, Sasatomi K, Mimura Y, Kawaguchi T, Tanikawa K (1997) Biliary secretion of endotoxin and pathogenesis of primary biliary cirrhosis. Yale J Biol Med 70:403-408 (Pubitemid 28262255)
98. Harada K, Kono N, Tsuneyama K, Nakanuma Y (1998) Cellkinetic study of proliferating bile ductules in various hepatobiliary diseases. Liver 18:277-284 (Pubitemid 28438536)
99. Harada K, Furubo S, Ozaki S, Hiramatsu K, Sudo Y, Nakanuma Y (2001) Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis. J Hepatol 34:500-506 (Pubitemid 32328505)
100. Poupon RE, Lindor KD, Pares A, Chazouilleres O, Poupon R, Heathcote EJ (2003) Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol 39:12-16 (Pubitemid 36724102)
101. Corpechot C, Carrat F, Bahr A, Chretien Y, Poupon RE, Poupon R (2005) The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 128:297-303 (Pubitemid 40431083)
102. Poupon RE, Balkau B, Eschwege E, Poupon R (1991) A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 324: 1548-1554
103. Podda M, Ghezzi C, Battezzati PM et al (1989) Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci 34:59S-65S (Pubitemid 20020166)
104. Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ (1998) A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 101:2790-2799 (Pubitemid 28294588)
105. Amaral JD, Castro RE, Sola S, Steer CJ, Rodrigues CM (2007) p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis. J Biol Chem 282:34250-34259 (Pubitemid 350159473)
106. Chapman R, Fevery J, Kalloo A et al (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51: 660-678
107. Fausa O, Schrumpf E, Elgjo K (1991) Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 11:31-39
108. Hov JR, BobergKM, Karlsen TH (2008) Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol 14:3781-3791
109. Aron JH, Bowlus CL (2009) The immunobiology of primary sclerosing cholangitis. Semin Immunopathol 31:383-397
110. Martins EB, Graham AK, Chapman RW, Fleming KA (1996) Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology 23:988-993 (Pubitemid 26137037)
111. Eksteen B, Grant AJ, Miles A et al (2004) Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med 200:1511-1517 (Pubitemid 39657298)
112. Dienes HP, Lohse AW, Gerken G et al (1997) Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 431:119-124 (Pubitemid 27393842)
113. Ansari B, Coates PJ, Greenstein BD, Hall PA (1993) In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170:1-8 (Pubitemid 23130577)
114. Kaserer K et al (1998) Characterization of the inflammatory infiltrate autoimmune cholangitis. A morphological and immunhistochemical study. Virchows Arch 432(3):217-222 (Pubitemid 28134871)